{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:30:48Z","timestamp":1790613048538,"version":"4.1.0"},"reference-count":50,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"unspecified","delay-in-days":24,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"European Union in the framework of European Funds Smart Growth and European Regional Development Fund.","award":["POIR.01.01.01-00-0615\/19"],"award-info":[{"award-number":["POIR.01.01.01-00-0615\/19"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2025,9,3]]},"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Ubiquitin-specific peptidase 7 (USP7) is a deubiquitinating enzyme that removes ubiquitin from specific protein substrates to modify their degradation rates thereby regulating crucial cellular processes integral to cancer. Conspicuously, overexpression of USP7 is strongly associated with the progression and poor prognosis in various cancers. Therefore, the design of potent and selective USP7 inhibitors poses an attractive therapeutic approach. The mechanism of action of USP7 inhibitors in cancer cells relies on MDM2 depletion and the restoration of p53.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this study, we present OAT-4828, a novel and highly potent USP7-selective lead compound with a pharmacokinetic profile suitable for an oral administration. In in vivo models of melanoma and colon cancers, we determine the antitumor activity of OAT-4828, revealing its significant influence on various immune cell populations by flow cytometry.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We provide evidence that OAT-4828 alters the tumor microenvironment, affecting immune cells including T cells, macrophages, and dendritic cells. As a result, OAT-4828 enhances antitumor functions, specifically improves T-cell activity, manifested by increased cytotoxicity, which is crucial for the effectiveness of OAT-4828 in vivo. Moreover, OAT-4828 changes the phenotype of macrophages and dendritic cells by decreasing the level of immunosuppressive proteins, such as programmed death-ligand 1. Translational results from the human co-culture system revealed the unexpected anti-angiogenic effect of the USP7 inhibitor, which was not observed when compared with an MDM2 inhibitor.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Overall, OAT-4828 demonstrates significant anticancer efficacy in melanoma and colon cancer models by activating the immune system, suggesting that USP7 may function as a checkpoint contributing to immunosuppression in cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jitc-2025-012287","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:30:18Z","timestamp":1758792618000},"page":"e012287","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Therapeutic inhibition of USP7 promotes antitumor immune responses"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4707-1722","authenticated-orcid":false,"given":"Angelika","family":"Muchowicz","sequence":"first","affiliation":[{"name":"Molecure SA, Warsaw, Poland"},{"name":"Laboratory of Cellular and Genetic Therapies, Center for Preclinical Research, Medical University of Warsaw, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna M","family":"G\u0142uchowska","sequence":"additional","affiliation":[{"name":"Molecure SA, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5197-7538","authenticated-orcid":false,"given":"Marcin M","family":"Grzybowski","sequence":"additional","affiliation":[{"name":"Molecure SA, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Szostakowska-Rodzos","sequence":"additional","affiliation":[{"name":"Molecure SA, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Rejczak","sequence":"additional","affiliation":[{"name":"Molecure SA, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Belczyk-Ciesielska","sequence":"additional","affiliation":[{"name":"Molecure SA, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7947-633X","authenticated-orcid":false,"given":"Mieszko M","family":"Wilk","sequence":"additional","affiliation":[{"name":"Molecure SA, Warsaw, Poland"},{"name":"Department of Immunology, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Krak\u00f3w, Lesser Poland Voivodeship, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Kikulska","sequence":"additional","affiliation":[{"name":"Molecure SA, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrycja","family":"Marzeta-Assas","sequence":"additional","affiliation":[{"name":"Molecure SA, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Zagozdzon","sequence":"additional","affiliation":[{"name":"Molecure SA, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Pomper","sequence":"additional","affiliation":[{"name":"Molecure SA, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Piwowar","sequence":"additional","affiliation":[{"name":"Molecure SA, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Bryla","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular and Genetic Therapies, Center for Preclinical Research, Medical University of Warsaw, Warsaw, Poland"},{"name":"Doctoral School, Medical University of Warsaw, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicja","family":"Wojciechowska","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular and Genetic Therapies, Center for Preclinical Research, Medical University of Warsaw, Warsaw, Poland"},{"name":"Doctoral School, Medical University of Warsaw, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Chrzanowski","sequence":"additional","affiliation":[{"name":"Molecure SA, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julita","family":"Nowicka","sequence":"additional","affiliation":[{"name":"Molecure SA, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Gzik","sequence":"additional","affiliation":[{"name":"Molecure SA, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukasz","family":"Joachimiak","sequence":"additional","affiliation":[{"name":"Molecure SA, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Koralewski","sequence":"additional","affiliation":[{"name":"Molecure SA, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"B\u0142aszczyk","sequence":"additional","affiliation":[{"name":"Molecure SA, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7957-2372","authenticated-orcid":false,"given":"Radoslaw","family":"Zagozdzon","sequence":"additional","affiliation":[{"name":"Laboratory of Cellular and Genetic Therapies, Center for Preclinical Research, Medical University of Warsaw, Warsaw, Poland"},{"name":"Department of Bioinformatics, Polish Academy of Sciences, Warszawa, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zbigniew","family":"Zas\u0142ona","sequence":"additional","affiliation":[{"name":"Molecure SA, Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,9,25]]},"reference":[{"key":"2026052108452147000_13.9.e012287.1","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-023-00633-y"},{"key":"2026052108452147000_13.9.e012287.2","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2016.00133","article-title":"DUBbing Cancer: Deubiquitylating Enzymes Involved in Epigenetics, DNA Damage and the Cell Cycle As Therapeutic Targets","volume":"7","author":"Pinto-Fernandez","year":"2016","journal-title":"Front Genet"},{"key":"2026052108452147000_13.9.e012287.3","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.16834"},{"key":"2026052108452147000_13.9.e012287.4","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-021-02208-z","article-title":"USP7 inhibition induces apoptosis in glioblastoma by enhancing ubiquitination of ARF4","volume":"21","author":"Pan","year":"2021","journal-title":"Cancer Cell Int"},{"key":"2026052108452147000_13.9.e012287.5","first-page":"1559","article-title":"Ubiquitin-specific protease 7 expression is a prognostic factor in epithelial ovarian cancer and correlates with lymph node metastasis","volume":"9","author":"Ma","year":"2016","journal-title":"Onco Targets Ther"},{"key":"2026052108452147000_13.9.e012287.6","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27682"},{"key":"2026052108452147000_13.9.e012287.7","doi-asserted-by":"publisher","DOI":"10.1172\/JCI120518"},{"key":"2026052108452147000_13.9.e012287.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2012.08.007"},{"key":"2026052108452147000_13.9.e012287.9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41418-024-01257-x","article-title":"Deubiquitinase USP7 stabilizes KDM5B and promotes tumor progression and cisplatin resistance in nasopharyngeal carcinoma through the ZBTB16\/TOP2A axis","volume":"31","author":"Zhang","year":"2024","journal-title":"Cell Death Differ"},{"key":"2026052108452147000_13.9.e012287.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.09.072"},{"key":"2026052108452147000_13.9.e012287.11","doi-asserted-by":"publisher","DOI":"10.4161\/cc.4.9.1981"},{"key":"2026052108452147000_13.9.e012287.12","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nature07290","article-title":"The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network","volume":"455","author":"Song","year":"2008","journal-title":"Nature New Biol"},{"key":"2026052108452147000_13.9.e012287.13","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms8023","article-title":"Molecular mechanism for USP7-mediated DNMT1 stabilization by acetylation","volume":"6","author":"Cheng","year":"2015","journal-title":"Nat Commun"},{"key":"2026052108452147000_13.9.e012287.14","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb1067"},{"key":"2026052108452147000_13.9.e012287.15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.0040027","article-title":"Structural basis of competitive recognition of p53 and MDM2 by HAUSP\/USP7: implications for the regulation of the p53-MDM2 pathway","volume":"4","author":"Hu","year":"2006","journal-title":"PLoS Biol"},{"key":"2026052108452147000_13.9.e012287.16","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-020-0949-z"},{"key":"2026052108452147000_13.9.e012287.17","doi-asserted-by":"crossref","DOI":"10.1186\/s12929-024-01004-x","article-title":"Targeting MDM2 in malignancies is a promising strategy for overcoming resistance to anticancer immunotherapy","volume":"31","author":"Sun","year":"2024","journal-title":"J Biomed Sci"},{"key":"2026052108452147000_13.9.e012287.18","doi-asserted-by":"crossref","first-page":"9332","DOI":"10.7150\/thno.47137","article-title":"USP7 targeting modulates anti-tumor immune response by reprogramming Tumor-associated Macrophages in Lung Cancer","volume":"10","author":"Dai","year":"2020","journal-title":"Theranostics"},{"key":"2026052108452147000_13.9.e012287.19","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1080\/08820139.2022.2083972","article-title":"USP7 Enables Immune Escape of Glioma Cells by Regulating PD-L1 Expression","volume":"51","author":"Li","year":"2022","journal-title":"Immunol Invest"},{"key":"2026052108452147000_13.9.e012287.20","doi-asserted-by":"crossref","DOI":"10.1186\/s40425-019-0770-2","article-title":"Mechanisms regulating PD-L1 expression on tumor and immune cells","volume":"7","author":"Chen","year":"2019","journal-title":"J Immunother Cancer"},{"key":"2026052108452147000_13.9.e012287.21","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.00233","article-title":"Targeting USP7-Mediated Deubiquitination of MDM2\/MDMX-p53 Pathway for Cancer Therapy: Are We There Yet?","volume":"8","author":"Qi","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"2026052108452147000_13.9.e012287.22","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.373738"},{"key":"2026052108452147000_13.9.e012287.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2005.10.033"},{"key":"2026052108452147000_13.9.e012287.24","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.5.1480"},{"key":"2026052108452147000_13.9.e012287.25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2010.01821.x"},{"key":"2026052108452147000_13.9.e012287.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2022.03.011"},{"key":"2026052108452147000_13.9.e012287.27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ebiom.2016.10.018","article-title":"Ubiquitin-specific Protease-7 Inhibition Impairs Tip60-dependent Foxp3 + T-regulatory Cell Function and Promotes Antitumor Immunity","volume":"13","author":"Wang","year":"2016","journal-title":"EBioMedicine"},{"key":"2026052108452147000_13.9.e012287.28","doi-asserted-by":"publisher","DOI":"10.1101\/gad.349848.122"},{"key":"2026052108452147000_13.9.e012287.29","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(02)01199-6"},{"key":"2026052108452147000_13.9.e012287.30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-34197-x"},{"key":"2026052108452147000_13.9.e012287.31","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-00888-3"},{"key":"2026052108452147000_13.9.e012287.32","doi-asserted-by":"publisher","DOI":"10.1007\/s10456-011-9210-8"},{"key":"2026052108452147000_13.9.e012287.33","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1648","article-title":"USP7 inhibitors suppress tumour neoangiogenesis and promote synergy with immune checkpoint inhibitors by downregulating fibroblast VEGF","volume":"14","author":"Jurisic","year":"2024","journal-title":"Clinical & Translational Med"},{"key":"2026052108452147000_13.9.e012287.34","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1038\/s41401-024-01263-2","article-title":"Inhibition of USP7 enhances CD8+ T cell activity in liver cancer by suppressing PRDM1-mediated FGL1 upregulation","volume":"45","author":"Sun","year":"2024","journal-title":"Acta Pharmacol Sin"},{"key":"2026052108452147000_13.9.e012287.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.04.006"},{"key":"2026052108452147000_13.9.e012287.36","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1148389","article-title":"The role of p53 in anti-tumor immunity and response to immunotherapy","volume":"10","author":"Carlsen","year":"2023","journal-title":"Front Mol Biosci"},{"key":"2026052108452147000_13.9.e012287.37","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/ar1842","article-title":"E3 ubiquitin ligases and their control of T cell autoreactivity","volume":"7","author":"Bonnevier","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"2026052108452147000_13.9.e012287.38","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2885"},{"key":"2026052108452147000_13.9.e012287.39","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80188-0"},{"key":"2026052108452147000_13.9.e012287.40","doi-asserted-by":"crossref","first-page":"115167","DOI":"10.1016\/j.biopha.2023.115167","article-title":"NFAT signaling dysregulation in cancer: Emerging roles in cancer stem cells","volume":"165","author":"Lin","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"2026052108452147000_13.9.e012287.41","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-024-05962-6","article-title":"Ubiquitin-specific protease 7 maintains c-Myc stability to support pancreatic cancer glycolysis and tumor growth","volume":"22","author":"Gu","year":"2024","journal-title":"J Transl Med"},{"key":"2026052108452147000_13.9.e012287.42","doi-asserted-by":"publisher","DOI":"10.1172\/JCI85747"},{"key":"2026052108452147000_13.9.e012287.43","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-1740"},{"key":"2026052108452147000_13.9.e012287.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.05.018"},{"key":"2026052108452147000_13.9.e012287.45","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.21037\/tcr-23-153","article-title":"Role for ubiquitin-specific protease 7 (USP7) in the treatment and the immune response to hepatocellular carcinoma: potential mechanisms","volume":"12","author":"Ying","year":"2023","journal-title":"Transl Cancer Res"},{"key":"2026052108452147000_13.9.e012287.46","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.0c00245"},{"key":"2026052108452147000_13.9.e012287.47","doi-asserted-by":"crossref","first-page":"106222","DOI":"10.1016\/j.leukres.2019.106222","article-title":"Evaluating dose-limiting toxicities of MDM2 inhibitors in patients with solid organ and hematologic malignancies: A systematic review of the literature","volume":"86","author":"Pi","year":"2019","journal-title":"Leuk Res"},{"key":"2026052108452147000_13.9.e012287.48","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000877","article-title":"Host genetics and tumor environment determine the functional impact of neutrophils in mouse tumor models","volume":"8","author":"van Elsas","year":"2020","journal-title":"J Immunother Cancer"},{"key":"2026052108452147000_13.9.e012287.49","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.1005727","article-title":"Highlights in USP7 inhibitors for cancer treatment","volume":"10","author":"Oliveira","year":"2022","journal-title":"Front Chem"},{"key":"2026052108452147000_13.9.e012287.50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PLoS Biol"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2025-012287","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:45:32Z","timestamp":1779378332000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2025-012287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":50,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9,25]]},"published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1136\/jitc-2025-012287"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2025-012287","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]}}}